COMMUNIQUÉS West-GlobeNewswire

Devonian Health Group Announces Canadian Patent for its Purgenesis™ anti-aging treatment
16/05/2018
QUEBEC CITY, May 16, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSX VENTURE:GSD) today announced that the Canadian Intellectual Property Office issued a Notice of Allowance [...]
Groupe Santé Devonian reçoit l’avis d’acceptation pour le brevet canadien de son traitement anti-âge Purgenesis(MC)
16/05/2018
QUÉBEC, 16 mai 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) annonçait aujourd’hui avoir reçu un avis d’acceptation de l’Office de la propriété intellectuelle [...]
LIDDS signs license agreement for prostate cancer drug Liproca® Depot with major Chinese pharma company
16/05/2018
UPPSALA, SWEDEN - LIDDS AB (publ) has signed a license agreement for Liproca® Depot with Jiangsu Ambition Medical, a Chinese pharmaceutical company specializing in global collaborations and in-licensing. Liproca® Depot [...]
Corcept Therapeutics Announces Presentations at the American Association of Clinical Endocrinologists 27th Annual Congress
16/05/2018
MENLO PARK, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT ), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe [...]
Bellerophon to Present Positive Results from Phase 2 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease at the American Thoracic Society 114th International Conference
16/05/2018
WARREN, N.J., May 16, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that it will present the [...]
Albireo Enrolls First Patient in Phase 3 PFIC Trial of A4250
16/05/2018
— Pivotal program in rare and life-threatening pediatric liver disorder underway — — Data intended to provide support for anticipated drug approval applications in US and EU — BOSTON, May 16, 2018 (GLOBE NEWSWIRE) -- [...]
Arrayit Corporation Scores 100% on Proficiency Testing Conducted by the College of American Pathologists
16/05/2018
Sunnyvale, CA, May 16, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that the company scored 100% on clinical laboratory proficiency testing [...]
Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update
16/05/2018
ORLANDO, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), an advanced specialty pharmaceutical company engaged in the treatment of serious and debilitating disorders through the [...]
Moleculin to Begin Clinical Trials at UMC Southwest Cancer Center
16/05/2018
HOUSTON, May 16, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX ) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Evolus Announces Progress with DWP-450 Regulatory Submissions
16/05/2018
FDA Issues Favorable EIR Letter Related to Manufacturing Facility Evolus Receives FDA Complete Response Letter with Comments Isolated to CMC Items Conference Call Scheduled for 8:30am ET / 5:30am PT IRVINE, Calif., May [...]
Solon Eiendom ASA : New share capital registered
16/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
GTX Corp First Quarter 2018 Summary
16/05/2018
Revenues increased 76%, Subscribers increased 79%, G&A decreased 17% LOS ANGELES, May 16, 2018 (GLOBE NEWSWIRE) -- GTX Corp. (OTCQB:GTXO), an IoT platform and leading provider of personal location GPS wearable [...]
Viveve Announces Initiation of VIVEVE II Clinical Study
16/05/2018
Results could support a marketing application for an expanded U.S. indication for the improvement of sexual function in women ENGLEWOOD, Colo., May 16, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE ), a [...]
MJ Biotech, Inc. Zen’s Tea House April’s Sales were over $190,000
16/05/2018
CHEYENNE, Wyo., May 16, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) announced today that Zen Hero, Inc. DBA Zen’s Tea House sales for the month of April were over $190,000 [...]
Solon Eiendom ASA : Approval and publication of prospectus
16/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
FDA Clears CASMED’s FORE-SIGHT Tissue Oximetry OEM Module
16/05/2018
Filing for first OEM Module combination product expected by year-end 2018 BRANFORD, Conn., May 16, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in medical products for non- [...]
Rezolute Announces Appointment of Keith Vendola as Chief Financial Officer
16/05/2018
LOUISVILLE, Colo., May 16, 2018 (GLOBE NEWSWIRE) -- Rezolute , Inc. (“Rezolute” or the “Company”) (OTCQB:RZLT) , a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies [...]
Delcath’s CHEMOSAT Included in German Treatment Guidelines for Melanoma Liver Metastases
16/05/2018
NEW YORK, May 16, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the German Guidelines [...]
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
16/05/2018
REDWOOD CITY, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]

Pages